About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 2,463 postmenopausal women with osteoporosis (mean age 69), 28 sites in 10 countries
- Sample size
- 2463
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
The teriparatide arm was open-label and served as a reference comparator, not a powered head-to-head test. The abstract text read does not give the fracture percentages. Trial registration NCT01343004.
Cited in
The ACTIVE trial
Abaloparatide · Research finding
StrongRaised blood calcium
Abaloparatide · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.